Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) shares dropped 3.6% during mid-day trading on Wednesday . The company traded as low as $3.21 and last traded at $3.26, with a volume of 578,908 shares traded. The stock had previously closed at $3.38.

KTOV has been the topic of a number of research reports. Zacks Investment Research upgraded Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $6.25 price target on the stock in a research note on Wednesday, April 27th. Rodman & Renshaw restated a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Saturday, May 14th.

The stock has a 50-day moving average price of $3.16 and a 200-day moving average price of $3.97. The stock’s market cap is $13.00 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.